Use of Intermittent Preventive Treatment of malaria, 2+ doses of SP/Fansidar (% of pregnant women)

  • Provider: World Bank
  • Source URL: http://data.worldbank.org/indicator/SH.MLR.SPF2.ZS
  • Catalog: Yearly from 2003 to 2016
  • Localized to: English
  • Tags: .
  • Description:

    Percentage of women with a live birth in the recent years preceding the survey who received 2+ doses of sulfadoxine-pyrimethamine (SP/Fansidar), at least one during an antenatal care visit. Intermittent Preventive Treatment (IPT) is preventive treatment with SP/Fansidar during an antenatal care (ANC) visit treatment with a dose of sulfadoxine-pyrimethamine (SP/Fansidar) to pregnant women at each scheduled antenatal visit after the first trimester, but not more frequently than once a month.

  • Dimensions

    • Country
      • Angola
      • Benin
      • Burkina Faso
      • Burundi
      • Cameroon
      • Central African Republic
      • Chad
      • Comoros
      • Congo, Dem. Rep.
      • Congo, Rep.
      • Cote d'Ivoire
      • Equatorial Guinea
      • Ethiopia
      • Gabon
      • Gambia, The
      • Ghana
      • Guinea
      • Guinea-Bissau
      • Guyana
      • Heavily indebted poor countries (HIPC)
      • Kenya
      • Lao PDR
      • Liberia
      • Madagascar
      • Malawi
      • Mali
      • Mauritania
      • Mozambique
      • Namibia
      • Niger
      • Nigeria
      • Pre-demographic dividend
      • Rwanda
      • Sao Tome and Principe
      • Senegal
      • Sierra Leone
      • Solomon Islands
      • Somalia
      • South Sudan
      • Sub-Saharan Africa
      • Sub-Saharan Africa (all income levels)
      • Sub-Saharan Africa (developing only)
      • Sub-Saharan Africa (excluding high income)
      • Sub-Saharan Africa (IDA & IBRD countries)
      • Sudan
      • Swaziland
      • Tanzania
      • Togo
      • Uganda
      • Vietnam
      • Zambia
      • Zimbabwe